FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, A.
Right arrow Articles by Weiner, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, A.
Right arrow Articles by Weiner, H. L.

The FASEB Journal, Vol 5, 2560-2566, Copyright © 1991 by The Federation of American Societies for Experimental Biology

REVIEWS

Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases

A Miller, DA Hafler and HL Weiner
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Recent advances in understanding antigen recognition at the level of the trimolecular complex have provided new approaches for selective immunotherapy. Many of these approaches have been applied successfully to the animal model experimental autoimmune encephalomyelitis, and some are being tested in the human disease multiple sclerosis. In addition, new approaches utilizing nonspecific modulation of immune function are being explored in animals and humans. Immunospecific therapy in autoimmune diseases will ultimately be based on understanding how the normal immune system maintains unresponsiveness to self and how this state of self-tolerance is broken. Strategies for specific immune intervention in human diseases based on components of the trimolecular complex will have to take into account the polymorphism of the major histocompatibility complex in humans and the degree of heterogeneity among autoimmune T cells that react with an autoantigen.


This article has been cited by other articles:


Home page
 J. Virol.Home page
H. Lewicki, A. Tishon, D. Homann, H. Mazarguil, F. Laval, V. C. Asensio, I. L. Campbell, S. DeArmond, B. Coon, C. Teng, et al.
T Cells Infiltrate the Brain in Murine and Human Transmissible Spongiform Encephalopathies
J. Virol., March 15, 2003; 77(6): 3799 - 3808.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
Materials and Methods
Multiple Sclerosis, February 1, 1999; 5(1): 003 - 9.
[PDF]

Home page
 Endocr. Rev.Home page
A. Hoek, J. Schoemaker, and H. A. Drexhage
Premature Ovarian Failure and Ovarian Autoimmunity
Endocr. Rev., February 1, 1997; 18(1): 107 - 134.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The Federation of American Societies for Experimental Biology.